Suppr超能文献

患者作为药物不良反应信息的直接来源。

Patients as a direct source of information on adverse drug reactions.

作者信息

Mitchell A S, Henry D A, Sanson-Fisher R, O'Connell D L

机构信息

Faculty of Medicine, University of Newcastle, Royal Newcastle Hospital, New South Wales, Australia.

出版信息

BMJ. 1988 Oct 8;297(6653):891-3. doi: 10.1136/bmj.297.6653.891.

Abstract

To determine whether patients should participate directly in detecting adverse reactions to drugs their ability to provide written reports of symptoms experienced during treatment with amoxycillin or trimethoprim-sulphamethoxazole was investigated. When compared with telephone interviews forms on which patients reported events were reliable (the observed agreement with the same statements posed during telephone calls was 85%, kappa = 0.56) and valid (sensitivity = 54%, specificity = 94%). Patients were also supplied with forms that invited them to report adverse reactions, and their perceptions were compared with those of a panel of experts, who were informed of all clinical events that had been reported during the detailed telephone interviews. Patients were more conservative than the experts in attributing clinical events to drug treatment. The extent of agreement varied and was notably poor for skin and bowel complaints (kappa = 0.13 in each case). The performance of event report forms and reaction report forms as instruments of detection was compared in a hypothetical situation in which the experts' views represented the "truth" about adverse reactions to a new drug. Event reporting had a higher sensitivity than reaction reporting (42% v 24%) but a lower specificity (58% v 98%). National centres monitoring adverse drug reactions should probably resist pressure to accept reports of reactions directly from the public, but a system based on large scale reporting of events might be valuable in aiding the early detection of symptomatic reactions to new drugs.

摘要

为了确定患者是否应直接参与药物不良反应的检测,对他们提供阿莫西林或甲氧苄啶 - 磺胺甲恶唑治疗期间所经历症状书面报告的能力进行了调查。与电话访谈相比,患者报告事件的表格是可靠的(在电话中提出相同陈述时观察到的一致性为85%,kappa值 = 0.56)且有效(敏感性 = 54%,特异性 = 94%)。还向患者提供了邀请他们报告不良反应的表格,并将他们的看法与专家小组的看法进行比较,专家小组了解了详细电话访谈期间报告的所有临床事件。在将临床事件归因于药物治疗方面,患者比专家更为保守。一致性程度各不相同,对于皮肤和肠道不适情况尤其差(每种情况的kappa值 = 0.13)。在假设专家观点代表新药不良反应“真相”的情况下,比较了事件报告表和反应报告表作为检测工具的性能。事件报告的敏感性高于反应报告(42%对24%),但特异性较低(58%对98%)。监测药物不良反应的国家中心可能应抵制直接接受公众反应报告的压力,但基于大规模事件报告的系统可能有助于早期发现新药的症状性反应。

相似文献

2
Adverse reactions to trimethoprim-sulfamethoxazole in hemophiliacs.
Am J Hematol. 1988 Feb;27(2):144-5. doi: 10.1002/ajh.2830270216.
4
Adverse reactions to Bactrim--a retrospective view.
Infection. 1987;15 Suppl 5:S227-30. doi: 10.1007/BF01643193.
5
Multiple system reaction to trimethoprim-sulfamethoxazole.
South Med J. 1987 Feb;80(2):275-6. doi: 10.1097/00007611-198702000-00040.
7
Adverse cutaneous drug reactions in AIDS.艾滋病患者的皮肤药物不良反应
Br J Dermatol. 1988 Oct;119(4):521-3. doi: 10.1111/j.1365-2133.1988.tb03256.x.
9
[A case report of acquired immunodeficiency syndrome (AIDS) with hypersensitivity reactions to trimethoprim-sulfamethoxazole].
Kansenshogaku Zasshi. 1988 Feb;62(2):180-4. doi: 10.11150/kansenshogakuzasshi1970.62.180.

引用本文的文献

本文引用的文献

3
Postmarketing follow-up at Group Health Cooperative of Puget Sound.普吉特海湾健康合作组织的上市后随访。
Pharmacotherapy. 1984 Mar-Apr;4(2):99-100. doi: 10.1002/j.1875-9114.1984.tb03328.x.
7
Patient-initiated postmarketing surveillance: a validation study.
J Clin Pharmacol. 1987 Nov;27(11):843-54. doi: 10.1002/j.1552-4604.1987.tb05578.x.
8
Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests.
Clin Pharmacol Ther. 1975 Jan;17(1):104-16. doi: 10.1002/cpt1975171104.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验